YOLFTbeta
Ikapharmindo Putramas Tbk.

Ikapharmindo Putramas Tbk.

IKPM · JK · Healthcare / Pharmaceutical Retailers

142.00IDR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close142.00
Open142.00
Day Range134.00 – 147.00
52-Week Range167.00 – 340.00
Volume521.10K
Market Cap294.82B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.51
50-Day Avg188.06
200-Day Avg207.86

About

PT Ikapharmindo Putramas Tbk engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. It operates through three segments: Non Pharma, Pharma, and Contract Manufacturing. The company offers prescription medicines in various areas, including neurology, psychiatry, dermatology, nephrology, gastroenterology, and nutraceuticals; and pharmaceuticals, vitamins, and over-the-counter products. It also provides hair and baby care products. PT Ikapharmindo Putramas Tbk was founded in 1978 and is headquartered in Jakarta Timur, Indonesia. PT Ikapharmindo Putramas Tbk is a subsidiary of PT Ikapharma Inti Mas.

Company Details

  • SectorHealthcare
  • IndustryPharmaceutical Retailers
  • CEOMr. . Kartono
  • Employees1.03K
  • HeadquartersJl. Pulogadung Raya No. 29, Jakarta Timur, Indonesia, 13920, Indonesia
  • Websitehttps://www.ikapharmindo.com

Leadership

  • Mr. . KartonoPresident Director · b. 1968

Financials

Income Statement

Currency: IDR2022-12-312023-12-312024-12-312025-12-31
Total Revenue398.73B441.14B412.07B363.57B
Growth (%)-+10.63%-6.59%-11.77%
Cost of Revenue217.45B251.73B225.38B214.15B
Gross Profit181.28B189.41B186.69B149.42B
Gross Margin45.46%42.94%45.30%41.10%
Operating Expense146.97B157.37B167.90B172.64B
Operating Income34.31B32.04B18.78B-23.23B
Operating Margin8.61%7.26%4.56%-6.39%
Net Income16.58B15.34B5.01B-28.78B
Net Income Margin4.16%3.48%1.22%-7.92%
Interest Expense805.00M369.61M684.62M686.55M
Interest Expense % of Total Revenue0.20%0.08%0.17%0.19%

Balance Sheet

Currency: IDR2022-12-312023-12-312024-12-312025-12-31
Total Assets387.55B463.38B491.38B464.00B
Total Liabilities210.85B218.67B245.25B245.26B
Total Equity176.70B244.71B246.12B218.74B
Cash10.88B44.29B23.83B47.02B

Cash Flow

Currency: IDR2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow3.75B25.94B-33.68B28.50B
Investing Cash Flow-4.83B-44.54B-2.99B-5.31B
Financing Cash Flow-2.35B52.01B16.21B0
Capital Expenditure4.86B45.18B3.65B6.02B
Dividends Paid0-3.79B0

Key Statistics & Ratios

Market Cap294.82B
Enterprise Value308.29B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.74
Price / Book0.00
Book Value131.56
Revenue (TTM)400.25B
Gross Profit (TTM)169.57B
EBITDA-7.39B
Profit Margin-4.19%
Operating Margin3.00%
Return on Equity-7.31%
Return on Assets-1.96%
Shares Outstanding1.68B
Shares Float336.93M
Beta0.51
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20241×
2.25Jun 5, 2024